Evaluation of thrombin-antithrombin complex, plasmin alpha2-plasmin inhibitor complex, soluble thrombomodulin, and tissue plasminogen activator-inhibitor complex efficiency [including the diagnostic efficiency for ovarian hyperstimulation syndrome (OHSS) and the differential diagnostic efficiency for mild–moderate and severe OHSS]. This evidence concerns the gene PLG and ovarian hyperstimulation syndrome.